drugset / Trial / NCT00104377
Induction of Immunogenicity With Different Doses of Grass MATA in Subjects Allergic to Grass and Rye Pollen
RandomizedParallel-groupSingle-blindTreatment
Summary
Grass MATA (modified pollen allergen tyrosine adsorbate) has been developed to provide pre-seasonal specific immunotherapy for patients with hypersensitivity to grass and rye pollen. Different doses of Grass MATA will be administered and immunological changes following this treatment will be assessed.
Timeline
- Start
- 2005-03
- Primary completion
- —
- Completion
- 2005-11
Outcome
Met primary endpoint
release “Grass MATA MPL Phase II dose ranging study - Primary endpoint met” allergytherapeutics.com ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Grass MATA | Other / unclassified | — | Subcutaneous |